Fulgent Genetics Inc (FLGT)

Net profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -167,825 -63,508 -48,682 -25,916 143,403 271,574 392,377 460,652 507,364 569,332 493,448 416,957 214,310 47,707 2,531 -459 -411 -2,168 -4,225 -5,605
Revenue (ttm) US$ in thousands 289,213 286,412 307,380 364,868 618,968 802,935 925,148 953,423 992,584 1,035,891 909,739 773,388 421,712 135,121 43,752 34,911 32,528 29,814 25,092 22,068
Net profit margin -58.03% -22.17% -15.84% -7.10% 23.17% 33.82% 42.41% 48.32% 51.12% 54.96% 54.24% 53.91% 50.82% 35.31% 5.78% -1.31% -1.26% -7.27% -16.84% -25.40%

December 31, 2023 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-167,825K ÷ $289,213K
= -58.03%

Fulgent Genetics Inc's net profit margin has shown a significant decline in recent quarters. The company experienced a notable decrease in net profit margin from the positive range in previous periods to negative figures in the most recent quarters. This trend indicates challenges in generating profits relative to its revenue, with Q4 2023 displaying the most severe decline at -58.03%. Overall, the declining trend in net profit margin raises concerns about the company's profitability and operational efficiency in recent periods. Further analysis of the company's cost structure and revenue generation strategies may be necessary to address these issues and improve profitability going forward.